PZ0340

PF-06737007

≥98% (HPLC)

• Synonym(e): 2-((3R,4S)-3-Fluoro-1-(2-(4-(trifluoromethoxy)phenyl)acetyl)piperidin-4-yloxy)-4-(2-hydroxy-2-methylpropoxy)benzamide, 2-[[(3R,4S)-3-Fluoro-1-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperidin-4-yl]oxy]-4-(2-hydroxy-2-methylpropoxy)benzamide, PF06737007
• Empirische Formel (Hill-System): C₂₅H₂₈F₄N₂O₆
• CAS-Nummer: 1863905-38-7
• Molekulargewicht: 528.49
• UNSPSC Code: 12352200
• PubChem Substance ID: 329823849
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 25 mg/mL, clear
• storage temp.: room temp
• SMILES string: F[C@@H]1CN(C(CC2=CC=C(OC(F)(F)F)C=C2)=O)CC[C@@H]1OC3=C(C(N)=O)C=CC(OCC(C)(C)O)=C3
• InChI key: AUTGNDRENPBZKA-UXHICEINSA-N

Beschreibung

Biochem/physiol Actions

PF-06737007 is pan tropomyosin-related kinase (Trk) inhibitor.

PF-06737007 is pan tropomyosin-related kinase inhibitor.

Other Notes

This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.

Sicherheitshinweise

• pictograms: GHS07
• signalword: Warning
• hcodes: H315,H319,H335
• pcodes: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• target_organs: Respiratory system
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable